Natco: Top and Latest News, Videos and Photos about Natco

Showing 93 results for

Indian share markets opened deep in the red, following the trend on SGX Nifty. (File Photo/Reuters)

Sensex Recovers After Plunging 800 Pts, Nifty Near 17,650; Tech Mahindra Down

4 min read . Updated: 21 Jan 2022

The Sensex tanked over 800 points to 59,104 levels, while the Nifty fell to as low as 17,613-mark in intraday trade. (MINT_PRINT)

Sensex trades marginally lower, Nifty near 17,800; IRCTC plummets 25%

4 min read . Updated: 29 Oct 2021

Next month, at least three Indian drugmakers will seek approval from the drug regulator following the completion of their own clinical trials for the drug in India.reuters

Molnupiravir, the covid drug that everyone wants to launch

2 min read . Updated: 04 Oct 2021

Top ten stocks that could be in the news today. (iStock)

Stocks to Watch: DHFL, HDFC Bank, Jet Airways, Kotak Mahindra Bank

2 min read . Updated: 18 Jun 2021

Shares of the company ended 4.43% down at ₹1,081.15 apiece on BSE on Thursday (Reuters)

Natco Pharma Q4 results: Net profit dips 43% to ₹53 crore

1 min read . Updated: 17 Jun 2021

On Wednesday, the BSE Sensex ended at 52,501.98, down 271.07 points or 0.51%. The Nifty was at 15,767.55 down 101.70 points or 0.64%. (Reuters)

Markets likely to be under pressure as Fed signals rate hike; PowerGrid in focus

2 min read . Updated: 17 Jun 2021

NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS) in the US market

Natco Pharma's marketing partner gets US FDA nod for anti-cancer drug

1 min read . Updated: 14 Jun 2021

MSN’s phase 3 trial is the third firm to start such a study for the drug in India, after Natco Pharma and Hetero Labs, whose trials are underway. Photo: Bloomberg

MSN Laboratories to start phase 3 clinical trial of covid-19 drug molnupiravir

1 min read . Updated: 25 May 2021

The move will improve the local treatment options available (Reuters)

Eli Lilly inks pact with Natco Pharma for Covid drug baricitinib

1 min read . Updated: 17 May 2021

(Photo: Reuters)

Covid-19 treatment: 5 Indian firms in licensing pact with Merck for oral drug

2 min read . Updated: 27 Apr 2021

×

Get alerts on WhatsApp

Set Preferences My Reads Feedback Redeem a Gift Card Logout